Evidence map›Paper›PMID 36285361›Full record

ArticleCNS neuroscience & therapeutics2023

Phenotypic expansion of KCNH1-associated disorders to include isolated epilepsy and its associations with genotypes and molecular sub-regional locations.

Mao-Qiang Tian, Ren-Ke Li, Fan Yang, Xiao-Mei Shu, Juan Li, Jing Chen, Long-Ying Peng, Xiao-Hua Yu, Chang-Jian Yang

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mao-Qiang TianDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.ORCID 0000-0003-3090-3801
Ren-Ke LiDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Fan YangCipher Gene LLC, Beijing, China.
Xiao-Mei ShuDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Juan LiDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Jing ChenDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Long-Ying PengDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Xiao-Hua YuDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Chang-Jian YangDepartment of Pediatrics, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Zunyi Medical University · CNCipher Gene (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGenotype-phenotypic correlation of KCNH1 variant remains elusive. This study aimed to expand the phenotypic spectrum of KCNH1 and explore the correlations between epilepsy and molecular sub-regional locations.

methodsWe performed whole-exome sequencing in a cohort of 98 patients with familiar febrile seizure (FS) or epilepsy with unexplained etiologies. The damaging effects of variants were predicted by protein modeling and multiple in silico tools. All reported patients with KCNH1 pathogenic variants with detailed neurological phenotypes were analyzed to evaluate the genotype-phenotype correlation.

resultsTwo novel KCNH1 variants were identified in three cases, including two patients with FS with inherited variant (p.Ile113Thr) and one boy with epilepsy with de novo variant (p.Arg357Trp). Variant Ile113Thr was located within the eag domain, and variant p.Arg357Trp was located in transmembrane domain 4 of KCNH1, respectively. Two patients experienced refractory status epilepticus (SE), of which one patient died of acute encephalopathy induced by SE. Further analysis of 30 variants in 51 patients demonstrated that de novo variants were associated with epileptic encephalopathy, while mosaic/somatic or germline variants cause isolated epilepsy/FS. All hotspot variants associated with epileptic encephalopathy clustered in transmembrane domain (S4 and S6), while those with isolated epilepsy/seizures or TBS/ZLS without epilepsy were scattered in the KCNH1.

conclusionsWe found two novel missense variants of KCNH1 in three individuals with isolated FS/epilepsy. Variants in the KCNH1 cause a spectrum of epileptic disorders ranging from a benign form of genetic isolated epilepsy/FS to intractable form of epileptic encephalopathy. The genotypes and variant locations help explaining the phenotypic variation of patients with KCNH1 variant.

Indexed as

Brain DiseasesEpilepsyEpilepsy, GeneralizedSeizures, FebrileEther-A-Go-Go Potassium ChannelsGenotypeHumansMutation, MissensePhenotypeEther-A-Go-Go Potassium ChannelsKCNH1 protein, humanepilepsyKCNH1 genestatus epilepticusTemple-Baraitser syndromeZimmermann-Laband syndrome

Identifiers

PMID36285361
PMCPMC9804083
OpenAlexW4307341500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.